The agency warned criminals may sell fake vaccines or infiltrate supply chains.
Category: Editors’ Pick
Here’s Why The U.K. Beat The U.S. To Approve A Covid-19 Vaccine For Emergency Use
The U.K. approved the Pfizer-BioNTech vaccine for emergency use Wednesday, with experts touting efficiency as a factor.
Walgreens Escalates VillageMd Clinic Rollout
Walgreens said it will open another 40 doctor-staffed clinics with its primary care partner VillageMD by summer’s end 2021 as part of its U.S. rollout over the next five years.
The New Coronavirus Vaccine Is Changing The Future Of Medicine
The success of mRNA vaccines could usher in a new era of medical science — not just for vaccines, but for cancer treatments, gene therapy, and more.
Study Suggests Covid-19 Was In The U.S. Weeks Earlier Than Thought, Before First Public Cases In China
The findings suggest that Covid-19 infections were present in the U.S. as early as December 2019.
Economists’ Solution: Pay Americans $1,000 To Get Covid-19 Vaccine
With Pfizer, Moderna, and Astrozeneca Covid-19 vaccine trials showing promise, the U.S. needs a way to inoculate enough of its population to achieve herd immunity. Paying Americans $1,000 to get the vaccine could be a simple, yet effective proposal.
United Nations Pleads For Aid As The Covid-19 Pandemic Pushes Millions Into Extreme Poverty
The agency is appealing for $35 billion in 2021 to reach millions of the world’s most vulnerable people with “life-saving support.”
On The Frontlines: Here’s How This Year’s 30 Under 30 Is Combating The Coronavirus
These 2021 30 Under 30 listmakers from the science and healthcare lists have devoted time, energy, and countless research hours to helping solve the Covid-19 crisis
30 Under 30 In Healthcare 2021: Fighting Covid, Mental Illness And Health Inequities
This exceptional group of entrepreneurs, researchers and clinicians are working to solve some of the most pressing healthcare challenges.
Indian Manufacturer Rejects Claim AstraZeneca-Oxford Covid-19 Vaccine Causes Severe Neurological Issues, Threatens Legal Action
The manufacturer says the trial participant’s illness has nothing to do with the vaccine.
